Similar articles

• The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.

  Ionescu A, Meitert E, Vasiliu S, Meitert T, Milicescu S, Sima F, Savulian C. Ionescu A, et al. Arch Roum Pathol Exp Microbiol. 1979 Jul-Dec;38(3-4):317-30. Arch Roum Pathol Exp Microbiol. 1979. PMID: 122594 No abstract available.
• Therapeutical pseudomonas aeruginosa antisera. Preparation, control and administration.

  Meitert T, Meitert E, Szegli G, Peligrad I. Meitert T, et al. Arch Roum Pathol Exp Microbiol. 1982 Apr-Jun;41(2):115-21. Arch Roum Pathol Exp Microbiol. 1982. PMID: 6816189 No abstract available.
• Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients.

  Ionescu A, Meitert E, Vasiliu S, Meitert T, Sima F, Savulian C, Milicescu S. Ionescu A, et al. Arch Roum Pathol Exp Microbiol. 1981 Oct-Dec;40(4):323-32. Arch Roum Pathol Exp Microbiol. 1981. PMID: 6803737 No abstract available.
• Pseudomonas vaccination and immunotherapy: an overview.

  Holder IA. Holder IA. J Burn Care Rehabil. 2001 Sep-Oct;22(5):311-20. doi: 10.1097/00004630-200109000-00004. J Burn Care Rehabil. 2001. PMID: 11570530 Review. No abstract available.
• Vaccines and immunotherapy against Pseudomonas aeruginosa.

  Döring G, Pier GB. Döring G, et al. Vaccine. 2008 Feb 20;26(8):1011-24. doi: 10.1016/j.vaccine.2007.12.007. Epub 2007 Dec 26. Vaccine. 2008. PMID: 18242792 Review.